MEDICATION-RELATED OSTEONECROSIS OF THE JAW ASSOCIATED WITH PAZOPANIB AND ORAL BISPHOSPHONATES.

MLA

Da Silva, Paula Verona Ragusa, et al. “Medication-Related Osteonecrosis of the Jaw Associated with Pazopanib and Oral Bisphosphonates.” Oral Surgery, Oral Medicine, Oral Pathology & Oral Radiology, vol. 134, no. 3, Sept. 2022, pp. e87–88. EBSCOhost, https://doi.org/10.1016/j.oooo.2022.01.044.

APA

Da Silva, P. V. R., Da Silva Filho, N. C., De Souza, F. H. P., Panucci, B. Z. M., Da Silva, E. V., Da Silveira, H. A., & León, J. E. (2022). Medication-Related Osteonecrosis of the Jaw Associated with Pazopanib and Oral Bisphosphonates. Oral Surgery, Oral Medicine, Oral Pathology & Oral Radiology, 134(3), e87–e88. https://doi.org/10.1016/j.oooo.2022.01.044

Chicago

Da Silva, Paula Verona Ragusa, Nilson Coelho Da Silva Filho, Fabrício Henrique Pereira De Souza, Beatriz Zamboni Martins Panucci, Evânio Vilela Da Silva, Heitor Albergoni Da Silveira, and Jorge Esquiche León. 2022. “Medication-Related Osteonecrosis of the Jaw Associated with Pazopanib and Oral Bisphosphonates.” Oral Surgery, Oral Medicine, Oral Pathology & Oral Radiology 134 (3): e87–88. doi:10.1016/j.oooo.2022.01.044.